Palvella Therapeutics (PVLA) Change in Taxes (2014 - 2015)
Palvella Therapeutics' (PVLA) quarterly Change in Taxes came in at $12474.0 in Q3 2015, down 74.58% year-on-year from $49064.0 in Q3 2014, and up 6991.71% on a QoQ basis from -$181.0 in Q2 2015.
Palvella Therapeutics (PVLA) Change in Taxes (2014 - 2015) Analysis & Trends
Palvella Therapeutics (PVLA) has 2 years of Change in Taxes data on file, last reported at $12474.0 in Q3 2015.
- On a quarterly basis, Change in Taxes fell 74.58% year-over-year to $12474.0 in Q3 2015; TTM through Sep 2015 was $59173.0, a N/A change from a year earlier, with the FY2014 full-year figure at $47940.0, up 423.44% from the prior year.
- Change in Taxes for Q3 2015 stood at $12474.0, up from -$181.0 in the prior quarter.
- Over the last five years, Change in Taxes for PVLA reached as high as $50564.0 in Q1 2014 and fell as low as -$2184.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 12,474.00 |
| Sep 30, 2015 | 12,474.00 |
| Jun 30, 2015 | -181.00 |
| Jun 30, 2015 | -181.00 |
| Mar 31, 2015 | -2,184.00 |
| Mar 31, 2015 | -2,184.00 |
| Sep 30, 2014 | 49,064.00 |
| Sep 30, 2014 | 49,064.00 |
| Jun 30, 2014 | 49,668.00 |
| Jun 30, 2014 | 49,668.00 |
| Mar 31, 2014 | 50,564.00 |
| Mar 31, 2014 | 50,564.00 |